← Eichor
Study identifier: NCT04490031 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Condition: Ketamine Adverse Reaction  ·  Sponsor: Universiti Kebangsaan Malaysia Medical Centre

PhasePhase 4
Planned participants140
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersYes

About this study

This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.

This description comes directly from the study's public registry record.

Talk to the study team

Muhammad Hafiz Ismail, MBBS  ·  6016 3354384  ·  muhdhafizismail88@gmail.com

Ian Chik, MD  ·  6012 3243404  ·  ianchikmd@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

University Kebangsaan Malaysia Medical centerBandar Tun Razak, Kuala Lumpur, MalaysiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04490031